Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)

Navigation and Search
photo of Rosheem Browne at right celebrating Match Day while holding his letter. Photo by UTHealth Houston

McGovern Medical School Class of 2024 discovers where they will spend the next steps in their careers as doctors

From an Army infantry veteran to a brain cancer survivor, the Class of 2024 at McGovern Medical School at UTHealth Houston found out together today at the Cooley University Life Center where they will take the next steps in their careers.

Students during last year's Match Day pin the map to show where they matched to their residences across the country.

McGovern Medical School’s Class of 2024 to meet their matches March 15

Meet some of the 227 students in the Class of 2024 at McGovern Medical School at UTHealth Houston who will be together on Friday, March 15, to celebrate Match Day, the day when they learn where they will take the next steps in their careers as physicians.

The UTHealth Houston research team included, from left, Caroline Praestholm, MS; Sudipta Sen, MD; Omonele Nwokolo, MD; Srikanth Sridhar, MD; Paul Potnuru, MD; Nadia Hernandez, MD; and Christina Goehl, MD. (Photo by UTHealth Houston)

Weight loss and diabetes management drug linked to increased residual gastric content before anesthesia

Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study published today in JAMA Surgery.

Jordan E. Lake, MD, MSc, professor of infectious diseases with McGovern Medical School at UTHealth Houston. (Photo by: UTHealth Houston)

UTHealth Houston research: semaglutide reduces severity of fatty liver disease in people with HIV

Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston.






More headlines »